FDA Designates Resmed Astral Ventilator Issue as Class I Recall

AI-generated NewsSnap summary based on source reporting.
Published: 2026-07-31
Category: health
Source: U.S. Food and Drug Administration (FDA)
Original source

The U.S. FDA has elevated a previously identified problem with the Resmed Astral Ventilator to a Class I Recall. This classification signifies that using the affected ventilators carries a reasonable probability of causing serious adverse health consequences or even death, underscoring a critical patient safety concern.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai